BREAST CANCER;
CANCER SURVIVAL;
CANCER TISSUE;
FLUORESCENCE IN SITU HYBRIDIZATION;
HISTOPATHOLOGY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
VALIDITY;
BREAST NEOPLASMS;
EARLY DETECTION OF CANCER;
ESTROGEN RECEPTOR BETA;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
PRACTICE GUIDELINES AS TOPIC;
PROGNOSIS;
RECEPTOR, ERBB-2;
RECEPTORS, PROGESTERONE;
REFERENCE STANDARDS;
UNITED STATES;
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43. (Pubitemid 46174133)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)
Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48-e72.
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
Erratum in Arch Pathol Lab Med. 2010 134 1101
Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010;134:907-922. Erratum in: Arch Pathol Lab Med. 2010;134:1101.
Clinical notice for american society of clinical oncology-college of American pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer
Hammond ME, Hayes DF, Wolff AC. Clinical notice for American Society of Clinical Oncology-College of American Pathologists Guideline Recommendations on ER/PgR and HER2 testing in breast cancer. J Clin Oncol. 2011;29:e458.
The role of the indispensable surgical pathologist in treatment planning for breast cancer
Hicks DG, Kulkarni S, Hammond ME. The role of the indispensable surgical pathologist in treatment planning for breast cancer. Arch Pathol Lab Med. 2008;132:1226-1227.
NCCN task force report: Estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry
Allred DC, Carlson RW, Berry DA, et al. NCCN task force report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw. 2009; 7(Suppl 6):S1-S21.